These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2579784)

  • 41. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
    Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
    Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain.
    Poulain P; Denier W; Douma J; Hoerauf K; Samija M; Sopata M; Wolfram G
    J Pain Symptom Manage; 2008 Aug; 36(2):117-25. PubMed ID: 18411010
    [TBL] [Abstract][Full Text] [Related]  

  • 43. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
    Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
    Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidural buprenorphine--a double-blind study of postoperative analgesia and side effects.
    Lanz E; Simko G; Theiss D; Glocke MH
    Anesth Analg; 1984 Jun; 63(6):593-8. PubMed ID: 6375465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transdermal buprenorphine in the treatment of chronic pain.
    Sittl R
    Expert Rev Neurother; 2005 May; 5(3):315-23. PubMed ID: 15938664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Failed pain control with sublingual application of buprenorphine].
    Overweg-van Kints J; Stricker BH
    Ned Tijdschr Geneeskd; 1987 Oct; 131(44):1973-4. PubMed ID: 3683616
    [No Abstract]   [Full Text] [Related]  

  • 47. High dose transdermal buprenorphine for moderate to severe pain in spanish pain centres--a retrospective multicenter safety and efficacy study.
    Barutell C; Camba A; González-Escalada JR; Rodríguez M;
    Pain Pract; 2008; 8(5):355-61. PubMed ID: 18662364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Long-term treatment with epidural opiates. A multicenter account of 125 patients].
    Andersen HB; Benveniste D; Bitsch-Larsen L; Carl P; Crawford M; Djernes M; Eriksen J; Grell AM; Henriksen H; Jansen E; Kaalund-Jørgensen HO; Laugesen L; Lønholdt C; Neumann P; Pedersen JE; Wolff J
    Ugeskr Laeger; 1982 Sep; 144(36):2633-7. PubMed ID: 6758261
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.
    Koizumi W; Toma H; Watanabe K; Katayama K; Kawahara M; Matsui K; Takiuchi H; Yoshino K; Araki N; Kodama K; Kimura H; Kono I; Hasegawa H; Hatanaka K; Hiraga K; Takeda F
    Jpn J Clin Oncol; 2004 Oct; 34(10):608-14. PubMed ID: 15591459
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical use of sublingual buprenorphine hydrochloride for analgesia in the early postoperative period].
    Lebedeva RN; Nikoda VV; Petrov RO; Kuleshova LA
    Anesteziol Reanimatol; 1996; (4):22-5. PubMed ID: 8975564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Peridural use of buprenorphine. Case report].
    Dahl HD
    Reg Anaesth; 1984 Apr; 7(2):56-8. PubMed ID: 6729155
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparative study about the analgesic effect of buprenorphine (author's transl)].
    Rigolot JC; Vergnes Y; Bouket JL; Gauthier-Lafaye P
    Anesth Analg (Paris); 1979; 36(7-8):317-21. PubMed ID: 525837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A trial of sublingual buprenorphine in cancer pain.
    Robbie DS
    Br J Clin Pharmacol; 1979; 7 Suppl 3(Suppl 3):315S-317S. PubMed ID: 380617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analgesic effects of sublingual buprenorphine.
    Edge WG; Cooper GM; Morgan M
    Anaesthesia; 1979 May; 34(5):463-7. PubMed ID: 474948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparative study of intramuscular buprenorphine and morphine in the treatment of chronic pain of malignant origin.
    Kjaer M; Henriksen H; Knudsen J
    Br J Clin Pharmacol; 1982 Apr; 13(4):487-92. PubMed ID: 7066163
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The monitored release of buprenorphine: results in the young.
    Harcus AW; Ward AE; Smith DW
    J Int Med Res; 1980; 8(2):153-5. PubMed ID: 7371972
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomised trial comparing buprenorphine and diamorphine for chest pain in suspected myocardial infarction.
    Hayes MJ; Fraser AR; Hampton JR
    Br Med J; 1979 Aug; 2(6185):300-2. PubMed ID: 383195
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multidose/observational, comparative clinical analgetic evaluation of buprenorphine.
    Mok MS; Lippmann M; Steen SN
    J Clin Pharmacol; 1981 Jul; 21(7):323-9. PubMed ID: 7263931
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relief of pain after surgery. A comparison of sublingual buprenorphine and intramuscular papaveretum.
    Fry EN
    Anaesthesia; 1979 Jun; 34(6):549-51. PubMed ID: 484814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.